Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study-Reference-Cited by-同舟云学术

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study

Published:2016-07 Issue:7 Volume:16 Page:809-818
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Rhein Joshua,Morawski Bozena M,Hullsiek Kathy Huppler,Nabeta Henry W,Kiggundu Reuben,Tugume Lillian,Musubire Abdu,Akampurira Andrew,Smith Kyle D,Alhadab Ali,Williams Darlisha A,Abassi Mahsa,Bahr Nathan C,Velamakanni Sruti S,Fisher James,Nielsen Kirsten,Meya David B,Boulware David R

Funder

National Institute of Neurological Disorders and Stroke (NINDS) and the Fogarty International Center

Grand Challenges Canada

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference34 articles.

1. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS;Park;AIDS,2009

2. Cost-effective diagnostic checklists for meningitis in resource-limited settings;Durski;J Acquir Immune Defic Syndr,2013

3. Combination antifungal therapy for cryptococcal meningitis;Day;N Engl J Med,2013